Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

5-ARI therapy may help prevent prostate cancer progression.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

HAIR-AN syndrome mainly affects obese women and can be improved with early diagnosis and treatment using insulin-sensitizing agents.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

Topical Ruxolitinib may safely treat severe hair loss.

Figs and coloquinte can affect blood sugar, but coloquinte can be toxic.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Calancardin B may help reduce inflammation in immune cells.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Nutritional care and education improved blood glucose control and nutrition in a Type 2 Diabetes patient.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.